Health & Life Competitors and Similar CompaniesClear all

Health & Life's competitors and similar companies include Agilent Technologies, Agappe Diagnostics, Zhejiang Orient Gene Biotech and Ortho Clinical Diagnostics US.

	Health & Life Health & Life is a company that specializes in the fields of cardiovascular disease, in-vitro diagnostics, and respiratory care products.	Agilent Technologies Agilent Technologies is a company that designs and manufactures laboratory instruments.	Agappe Diagnostics Agappe Diagnostics is a company that produces clinical chemistry reagents and distributes in-vitro diagnostics equipment.	Zhejiang Orient Gene Biotech Zhejiang Orient Gene Biotech (浙江东方基因生物制品股份有限公司) is a company that manufactures and sells vitro diagnostic products,	Ortho Clinical Diagnostics US Ortho Clinical Diagnostics US is a company specializing in in vitro diagnostics.
Founding Date	Founding Date 1996	Founding Date 1999	Founding Date 1994	Founding Date 2005	Founding Date 1994
Type	Type Public	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics
Locations	Locations HQ	Locations Santa Clara, US HQ Victoria, AU Wien, AT Zaventem, BE Barueri, BR Mississauga, CA Beijing, CN see more	Locations Kochi, IN HQ Bengaluru, IN Kolkata, IN Mumbai, IN Nellad, IN New Delhi, IN Cham, CH	Locations Huzhou, CN HQ	Locations Raritan, US HQ Rochester, US
Employees	Employees N/A	Employees 18,0001% decrease	Employees 1,1652% increase	Employees 2,231	Employees 1,650
Valuation ($)	Valuation ($) N/A	Valuation ($) 37.7 b	Valuation ($) N/A	Valuation ($) 945.9 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) NT$706.4m (FY, 2024)	Revenue (est.) $6.9b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ¥910.7m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods NT$535.3m (FY, 2024)	Cost of goods $3.3b (FY, 2025)	Cost of goods N/A	Cost of goods ¥560.9m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit NT$186.8m (FY, 2024)	Gross profit $3.6b (FY, 2025)	Gross profit N/A	Gross profit ¥366.6m (FY, 2025)	Gross profit N/A
Net income	Net income NT$24.2m (FY, 2024)	Net income $1.3b (FY, 2025)	Net income N/A	Net income (¥597.4m) (FY, 2025)	Net income N/A